Clearpoint Neuro Inc. · NASDAQ:CLPT
Burnett Joseph sold 61,843 Clearpoint Neuro Inc. shares (Form 4)
Traded Jun 17, 2026 · Filed Jun 22, 2026
On Jun 17, 2026, Burnett Joseph (Director, CEO and President) sold 61,843 Clearpoint Neuro Inc. shares at an average US$17.79 for US$1.1M under a trading plan, leaving 191,388 shares. Filed Jun 22, 2026 (Form 4).
- Sold
- 61,843 shares
- Price
- US$17.79 average (US$17.79 to US$17.94)
- Value
- US$1.1M
- Holding after
- 191,388 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | Option exercise | 60,000 | US$2.50 | 176,842 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 60,000 | US$17.79 | 116,842 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 1,843 | US$17.94 | 191,388 | Indirect |
Source
Related
- Clearpoint Neuro Inc.
- Burnett Joseph
- Clearpoint Neuro Inc. shareholders
- Form 4 · Burnett Joseph · Sep 3, 2026
- Form 4 · Burnett Joseph · Jul 2, 2026
- Form 4 · Burnett Joseph · Jul 1, 2026
- Form 4 · Fletcher R John · Oct 2, 2026
- Form 4 · Richards Timothy T. · Oct 2, 2026
- Schedule 13G/A · Mak Capital One LLC · Aug 12, 2026
- Schedule 13G/A · Bigger Michael · Aug 4, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026